CRIS Current Research Information System

LUNGHI, CARLOTTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.365
NA - Nord America 1.787
EU - Europa 1.306
SA - Sud America 180
AF - Africa 86
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.746
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.705
SG - Singapore 956
CN - Cina 909
VN - Vietnam 654
IT - Italia 508
HK - Hong Kong 261
KR - Corea 207
DE - Germania 185
BR - Brasile 142
IN - India 136
SE - Svezia 127
FR - Francia 90
GB - Regno Unito 87
JP - Giappone 72
CA - Canada 54
IE - Irlanda 53
RU - Federazione Russa 52
NL - Olanda 47
FI - Finlandia 40
CI - Costa d'Avorio 29
MX - Messico 27
AT - Austria 26
BG - Bulgaria 26
TH - Thailandia 23
JO - Giordania 21
ID - Indonesia 19
PH - Filippine 19
ZA - Sudafrica 18
AR - Argentina 17
AU - Australia 16
BD - Bangladesh 16
TR - Turchia 15
CH - Svizzera 14
PL - Polonia 14
ES - Italia 13
IQ - Iraq 10
TG - Togo 10
PK - Pakistan 9
SA - Arabia Saudita 9
MA - Marocco 8
TW - Taiwan 7
UA - Ucraina 7
CO - Colombia 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
BE - Belgio 4
EC - Ecuador 4
IR - Iran 4
CL - Cile 3
DK - Danimarca 3
KE - Kenya 3
PY - Paraguay 3
RS - Serbia 3
SC - Seychelles 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IL - Israele 2
MY - Malesia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
SN - Senegal 2
VE - Venezuela 2
BY - Bielorussia 1
DZ - Algeria 1
GH - Ghana 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MM - Myanmar 1
PE - Perù 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.746
Salva come PNG Salva come JPEG
Città #
Singapore 651
Hefei 453
San Jose 260
Hong Kong 247
Santa Clara 208
Ho Chi Minh City 202
Seoul 199
Ashburn 195
Hanoi 163
Boardman 82
Bologna 76
Council Bluffs 76
Beijing 66
Tokyo 64
Dallas 61
Princeton 59
Lauterbourg 57
Dublin 52
Frankfurt am Main 49
Los Angeles 46
Bengaluru 45
Florence 43
Milan 43
Rome 42
Chandler 37
New York 32
Southend 31
Abidjan 29
Helsinki 26
Nuremberg 26
Redondo Beach 26
Sofia 26
Da Nang 24
Haiphong 24
Seattle 24
Fairfield 23
Turin 23
Amman 21
Buffalo 21
The Dalles 21
Des Moines 20
Ann Arbor 19
Montreal 19
Modena 17
Jakarta 16
São Paulo 16
Chicago 15
Vienna 15
Woodbridge 15
Forlì 14
London 14
Tongling 13
Bangkok 12
Mexico City 12
Shanghai 12
Falkenstein 11
Guangzhou 11
Olalla 11
San Diego 11
Bern 10
Ha Long 10
Lappeenranta 10
Lomé 10
Warsaw 10
Berlin 9
Bühl 9
Cesena 9
Houston 9
Orem 9
Phủ Lý 9
Amsterdam 8
Berkeley 8
Wilmington 8
Brakpan 7
Cambridge 7
Medford 7
Pescara 7
Phoenix 7
Quận Bình Thạnh 7
Atlanta 6
Can Tho 6
Embrun 6
Istanbul 6
Mumbai 6
Munich 6
Paris 6
Perth 6
Reggio Emilia 6
Rio de Janeiro 6
Stockholm 6
Tianjin 6
Toronto 6
Ankara 5
Biên Hòa 5
Buenos Aires 5
Bắc Ninh 5
Chennai 5
Denver 5
Elk Grove Village 5
Hải Dương 5
Totale 4.414
Salva come PNG Salva come JPEG
Nome #
Morbidities and mortality of diagnosed attention deficit hyperactivity disorder (ADHD) over the youth lifespan: A population-based retrospective cohort study 331
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 283
Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study 264
Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective 191
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 177
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 172
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies 159
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency 148
Early career researchers’ perspectives and roles in patient-oriented research 145
SYNHETIC IMMUNOGENIC GLYCOCONJUGATE FOR MELANOMA IMMUNOTHERAPY 143
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study 143
Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations 139
Comorbidity, trauma, and mortality in children and young adults using ADHD medications in Quebec between 2000 and 2020 137
The interface of depression and diabetes: treatment considerations 135
Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec’s health services register cohort 132
ADHD Medication Use and Psychiatric Comorbidity, Trauma and Mortality in Children and Young Adults: A Cohort Study from Quebec, Canada 127
Definition and validation of case detection algorithms using Quebec medico-administrative databases (med-echo and ramq) for depression among seniors 118
Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups 115
Medication use in Italian nursing homes: preliminary results from the national monitoring system 114
Health care system costs related to potentially inappropriate medication use involving opioids in older adults in Canada 114
Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study 113
ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study 111
Medication use in the year before and after a diagnosis of cluster B personality disorder: Trends and patterns between 2002 and 2018 in Quebec, Canada 109
What methods are used to study the association between medication adherence trajectories, estimated with the group-based trajectory modeling (GBTM) method, and health-related outcomes?—a protocol for a systematic review 108
Global prevalence of antidepressant utilization in the community: A protocol for a systematic review 108
What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System 108
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS 107
Trends in medication use during the COVID-19 pandemic in Quebec, Canada 106
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward 105
Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system 100
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health 96
Patient and health system factors associated with potentially inappropriate opioid use in non-cancer community-dwelling older adults 93
Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016 93
Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada 93
Association between stimulant and non-stimulant ADHD medications and completed suicide in adolescents and adults: A population-based nested case-control study 89
Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian 85
Trends of polypharmacy among older adults with schizophrenia in Quebec, Canada between 2000 and 2017 81
Environmental sustainability-an essential component of rational use of medicines 79
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation 77
Association Between Depression And Discontinuation With Antidiabetic Drugs 75
Economic evaluations of interventions to optimize medication use in older adults with polypharmacy and multimorbidity: A systematic review 72
Scholarly publishing depends on peer reviewers 68
Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment 68
Incidence of depression and associated factors in patients with type 2 diabetes in Quebec, Canada 67
Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter? 67
Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes: A nested case-control study 66
Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression 66
The impact of incident depression on medication adherence in patients with type 2 diabetes 64
The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey 63
Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health 62
The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs 61
Changes in self-rated physical and mental health and life satisfaction associated with opioid and potentially inappropriate opioid prescribing in primary care older adults 60
Sialylexoenitols as precursors for new analogues of sialidase inhibitors 60
The Association Between Depression and Medication Non-Adherence in Type 2 Diabetes: A Population-Based Cohort Study 59
Prevalence of Depression in Patients with Type 2 Diabetes (T2D) in Quebec 59
Use of Quebec medico-administrative databases for mental health studies: Opportunities, methodological challenges and limitations – The case of depression among diabetic subjects 58
Benefits, risks and impacts on quality of life of medications used in multimorbid older adults: a Delphi study 58
Dosing of Cannabinoids Associated with an Opioid-Sparing Effect: A Systematic Review of Longitudinal Studies 56
Stereoselective synthesis of 1,3-disaccharides through diels-alder reactions: Part 2[ ]: Convenient protecting groups for heterodienes and conformational evaluations 53
Structural study of liposomes loaded with a GM3 lactone analogue for the targeting of tumor epitopes 52
Alternative mechanistic paths in the Hetero-Diels-Alder reaction of α-oxothiones: A theoretical study 51
Risk of Psychotic Disorders Among Patients with Medical Cannabis Authorization: A Longitudinal Cohort Study 50
Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms 49
Stable GM3 lactone mimetic raises antibodies specific for the antigens expressed on melanoma cells 48
Synthesis, conformational studies, binding assessment and liposome insertion of a thioether-bridged mimetic of the antigen GM3 ganglioside lactone 47
Utilization of Health Care Services by Patients With Cluster B Personality Disorders or Schizophrenia 45
Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults 43
CoViD-19 pandemic and incidence of depression in people with diabetes: mental health unmet needs? 38
Factors associated with potentially inappropriate opioid use in community-living older adults consulting in primary care 37
From adoption to impact: linking prescribing tools to clinical outcomes—authors’ response 31
Treatment sequences in moderate-to-severe psoriasis: a hospital-based retrospective analysis 27
Vertigo and Balance Disorders - The Role of Osteopathic Manipulative Treatment: A Systematic Review (vol 23, pg 1, 2020) 16
Totale 6.944
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 2 0 2
2021/2022363 0 0 3 0 2 0 81 44 24 17 106 86
2022/2023528 38 26 36 42 48 22 47 56 106 43 38 26
2023/2024392 23 35 30 22 31 58 30 21 24 52 46 20
2024/20251.719 104 162 136 104 254 90 103 62 54 83 176 391
2025/20263.932 614 642 438 321 302 167 513 210 503 222 0 0
Totale 6.944